Phase I-II clinical trial of oxaliplatin, fludarabine, cytarabine, and rituximab therapy in aggressive relapsed/refractory chronic lymphocytic leukemia or Richter syndrome
scientific article
Author/s
author: Hagop Kantarjian, William G Wierda, Susan O'Brien, Michael J. Keating, William Plunkett, Apostolia Maria Tsimberidou, Xavier C Badoux, Chronic Lymphocytic Leukemia Research Consortium, Sijin Wen, Jeffrey A Jones
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.